Ketorolac Ophthalmic Drops, Solution 0.4pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ketorolac: Ophthalmic drops, solution (0.4%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Ketorolac 0.4% Ophth Soln
Drug Image file default-drug-image.png
Ketorolac 0.4% Ophth Soln

What is this Medicine?

KETOROLAC (kee toe ROLE ak) is a non-steroidal anti-inflammatory drug (NSAID). This eye drop is used to treat pain and swelling after eye surgery. It is also used to decrease swelling or redness caused by allergies.

CVS Pharmacy Patient Statistics for Ketorolac: Ophthalmic drops, solution(0.4%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Ketorolac Tromethamine 0.4% Ophthalmic Solution

NDC: 607580773
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Conjunctivitis, Ocular Surgery, Postoperative Ocular Inflammation, Ocular Pain, Ocular Pruritus

Storage Information
Store between 59 to 77 degrees F
Ketorolac Tromethamine 0.4% Ophthalmic Solution

Reported Side Effects for Ketorolac Tromethamine 0.4% Ophthalmic Solution

Dry Eyes Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Red Eyes Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Iris (Eye) Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Eye Inflammatoin Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Eye Inflammation Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Eye Pain Incidence:
1.0-40.0%*
Severity: MILD
Onset: EARLY
Eye Infection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Corneal Edema Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Eye Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Secretion Of Tears Incidence:
5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ketorolac

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.